M. Guirado

903 total citations
24 papers, 361 citations indexed

About

M. Guirado is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, M. Guirado has authored 24 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in M. Guirado's work include Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Diagnosis and Treatment (12 papers) and Lung Cancer Research Studies (5 papers). M. Guirado is often cited by papers focused on Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Diagnosis and Treatment (12 papers) and Lung Cancer Research Studies (5 papers). M. Guirado collaborates with scholars based in Spain, Greece and United Kingdom. M. Guirado's co-authors include Rosario García‐Campelo, Óscar Juan, Enric Carcereny, Mariano Provencio, José Trigo, Margarita Majem, Noemı́ Reguart, Amelia Insa, Yolanda García García and Rafael López Castro and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Journal of Thoracic Oncology.

In The Last Decade

M. Guirado

24 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Guirado Spain	9	254	202	54	37	30	24	361
Sjaak Burgers Netherlands	11	336 1.3×	158 0.8×	25 0.5×	33 0.9×	36 1.2×	21	456
Fernando Barata Portugal	11	294 1.2×	262 1.3×	72 1.3×	54 1.5×	16 0.5×	61	438
J.W.G. van Putten Netherlands	9	229 0.9×	225 1.1×	67 1.2×	26 0.7×	18 0.6×	11	402
G. Lopes United States	8	158 0.6×	198 1.0×	22 0.4×	48 1.3×	20 0.7×	32	263
Adlinda Alip Malaysia	8	304 1.2×	250 1.2×	64 1.2×	69 1.9×	26 0.9×	28	377
M. Martín Jiménez Spain	10	133 0.5×	200 1.0×	27 0.5×	79 2.1×	30 1.0×	56	323
Rosario Francesco Di Stefano Italy	8	153 0.6×	105 0.5×	70 1.3×	62 1.7×	24 0.8×	25	276
Melissa A.L. Vyfhuis United States	10	201 0.8×	182 0.9×	28 0.5×	49 1.3×	60 2.0×	30	390
Valeria Stati Italy	11	99 0.4×	182 0.9×	61 1.1×	27 0.7×	29 1.0×	25	319
Humera Khurshid United States	11	137 0.5×	190 0.9×	70 1.3×	41 1.1×	25 0.8×	24	342

Countries citing papers authored by M. Guirado

Since Specialization

Citations

This map shows the geographic impact of M. Guirado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Guirado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Guirado more than expected).

Fields of papers citing papers by M. Guirado

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Guirado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Guirado. The network helps show where M. Guirado may publish in the future.

Co-authorship network of co-authors of M. Guirado

This figure shows the co-authorship network connecting the top 25 collaborators of M. Guirado. A scholar is included among the top collaborators of M. Guirado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Guirado. M. Guirado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Calvo, Virginia, Enric Carcereny, Delvys Rodríguez‐Abreu, et al.. (2024). Family history of cancer and lung cancer: Utility of big data and artificial intelligence for exploring the role of genetic risk. Lung Cancer. 195. 107920–107920. 3 indexed citations

Martín-Martorell, Paloma, Francisco Aparisi, María José Domper-Arnal, et al.. (2024). A real‑world study of clinical characteristics, treatment sequence and outcomes of patients with non-small cell lung cancer and EGFR exon 20 insertion mutations. Clinical & Translational Oncology. 27(6). 2568–2578. 1 indexed citations

Arenas-Jiménez, J.J., Alberto Fernández‐Villar, Antonio Gómez‐Caamaño, et al.. (2024). Certification system for multidisciplinary thoracic tumour boards. Clinical & Translational Oncology. 27(5). 2037–2040. 1 indexed citations

Sánchez‐Beato, Margarita, Míriam Méndez, M. Guirado, et al.. (2023). A genetic profiling guideline to support diagnosis and clinical management of lymphomas. Clinical & Translational Oncology. 26(5). 1043–1062. 7 indexed citations

Calvo, Virginia, Carlos Camps, Enric Carcereny, et al.. (2023). Difficulties on the access to innovative targeted therapies for lung cancer in Spain. Clinical & Translational Oncology. 26(3). 597–612. 3 indexed citations

Provencio, Mariano, Enric Carcereny, Rafael López Castro, et al.. (2023). Real-world treatment patterns and survival outcomes for patients with stage III non-small cell lung cancer in Spain: a nationwide cohort study. Translational Lung Cancer Research. 12(10). 2113–2128. 7 indexed citations

Guirado, M., et al.. (2022). Clinical impact of delays in the management of lung cancer patients in the last decade: systematic review. Clinical & Translational Oncology. 24(8). 1549–1568. 26 indexed citations

Calvo, Virginia, Manuel Cobo, Delvys Rodríguez‐Abreu, et al.. (2022). 39P Determination of essential biomarkers in lung cancer: A real-world data study in Spain. Annals of Oncology. 33. S50–S50. 1 indexed citations

Nadal, Ernest, Delvys Rodríguez‐Abreu, Bartomeu Massutí, et al.. (2022). Updated analysis from the ATEZO-BRAIN trial: Atezolizumab plus carboplatin and pemetrexed in patients with advanced nonsquamous non–small cell lung cancer with untreated brain metastases.. Journal of Clinical Oncology. 40(16_suppl). 9010–9010. 14 indexed citations

10.

Aix, Santiago Ponce, Enric Carcereny, Joaquim Bosch‐Barrera, et al.. (2021). 160P Pembrolizumab re-challenge in patients with relapsed non-small cell lung cancer (NSCLC): A preliminary report of the REPLAY phase II trial - cohort I. Annals of Oncology. 32. S1450–S1450. 5 indexed citations

11.

Franco, Fernando, M. Guirado, Natividad Martínez-Banaclocha, et al.. (2021). Multicenter Study of the Seroprevalence of Antibodies against Covid-19 in Patients with Lymphoma: An Analysis of the Oncological Group for the Treatment and Study of Lymphomas (Gotel). Current Oncology. 28(2). 1249–1255. 1 indexed citations

12.

Nadal, Ernest, Joaquim Bosch‐Barrera, S. Cedrés, et al.. (2021). SEOM clinical guidelines for the treatment of malignant pleural mesothelioma (2020). Clinical & Translational Oncology. 23(5). 980–987. 18 indexed citations

13.

Guirado, M., et al.. (2021). Quality indicators and excellence requirements for a multidisciplinary lung cancer tumor board by the Spanish Lung Cancer Group. Clinical & Translational Oncology. 24(3). 446–459. 17 indexed citations

14.

Nadal, Ernest, Bartomeu Massutí, Rafael López Castro, et al.. (2021). OA09.02 Atezo-Brain: Single Arm Phase II Study of Atezolizumab Plus Chemotherapy in Stage IV NSCLC With Untreated Brain Metastases. Journal of Thoracic Oncology. 16(10). S863–S863. 13 indexed citations

15.

Romero, Atocha, Miguel Ángel Molina‐Vila, Eloísa Jantus‐Lewintre, et al.. (2020). Comprehensive cross-platform comparison of methodologies for noninvasive EGFR mutation testing: Results of the RING observational trial.. Journal of Clinical Oncology. 38(15_suppl). e21518–e21518. 1 indexed citations

16.

Cruz‐Merino, Luis de la, Alejandro Martı́n, Eduardo Ríos, et al.. (2020). Lenalidomide plus R-GDP (R2-GDP) in relapsed/refractory diffuse large B-cell lymphoma: Final results of the R2-GDP-GOTEL trial.. Journal of Clinical Oncology. 38(15_suppl). 8019–8019. 2 indexed citations

17.

Provencio, Mariano, Enric Carcereny, Delvys Rodríguez‐Abreu, et al.. (2019). Lung cancer in Spain: information from the Thoracic Tumors Registry (TTR study). Translational Lung Cancer Research. 8(4). 461–475. 43 indexed citations

18.

Rodríguez‐Abreu, Delvys, M. Guirado, Carmen Herrero, et al.. (2019). Biomarker testing of lung cancer in Spain. Annals of Oncology. 30. v749–v749. 1 indexed citations

19.

Carcereny, Enric, M. Guirado, Carmen Herrero, et al.. (2019). Tobacco use in lung cancer (LC) patients (p) in Spain. Annals of Oncology. 30. v749–v749. 1 indexed citations

20.

Majem, Margarita, Óscar Juan, Amelia Insa, et al.. (2018). SEOM clinical guidelines for the treatment of non-small cell lung cancer (2018). Clinical & Translational Oncology. 21(1). 3–17. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact